ATE535805T1 - Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen - Google Patents

Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen

Info

Publication number
ATE535805T1
ATE535805T1 AT08728418T AT08728418T ATE535805T1 AT E535805 T1 ATE535805 T1 AT E535805T1 AT 08728418 T AT08728418 T AT 08728418T AT 08728418 T AT08728418 T AT 08728418T AT E535805 T1 ATE535805 T1 AT E535805T1
Authority
AT
Austria
Prior art keywords
diagnosing
detecting autoantibodies
characterizing
diseases
characterizing diseases
Prior art date
Application number
AT08728418T
Other languages
English (en)
Inventor
Douglas D Taylor
Cicek Gercel-Taylor
Original Assignee
Univ Louisville Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Louisville Res Found filed Critical Univ Louisville Res Found
Application granted granted Critical
Publication of ATE535805T1 publication Critical patent/ATE535805T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT08728418T 2007-01-26 2008-01-28 Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen ATE535805T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89764107P 2007-01-26 2007-01-26
PCT/US2008/052223 WO2008092164A2 (en) 2007-01-26 2008-01-28 Methods of detecting autoantibodies for diagnosing and characterizing disorders

Publications (1)

Publication Number Publication Date
ATE535805T1 true ATE535805T1 (de) 2011-12-15

Family

ID=39645229

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08728418T ATE535805T1 (de) 2007-01-26 2008-01-28 Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen

Country Status (12)

Country Link
US (2) US20100055724A1 (de)
EP (2) EP2111550B1 (de)
JP (1) JP5175864B2 (de)
CN (1) CN101657719A (de)
AT (1) ATE535805T1 (de)
AU (1) AU2008207746B2 (de)
BR (1) BRPI0806437A2 (de)
CA (1) CA2676148A1 (de)
ES (1) ES2378490T3 (de)
IL (1) IL200026A (de)
WO (1) WO2008092164A2 (de)
ZA (1) ZA200905004B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8700335B2 (en) * 2006-05-18 2014-04-15 Caris Mpi, Inc. System and method for determining individualized medical intervention for a disease state
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
GB2459228B (en) 2007-07-25 2012-06-20 Univ Louisville Res Found Exosome-associated microrna as a diagnostic marker
EP3075864A1 (de) * 2008-10-14 2016-10-05 Caris MPI, Inc. Gen und genexprimierte zielproteine zur darstellung von biomarkermustern und signatursets nach tumortyp
DE102008053503B4 (de) * 2008-10-28 2011-04-28 Justus-Liebig-Universität Giessen Immunologischer Test zum Nachweis von Autoantikörpern gegen testikuläre Antigene
JP2012507300A (ja) * 2008-10-30 2012-03-29 カリス ライフ サイエンシズ ルクセンブルク ホールディングス Ｒｎａパターンを評価する方法
EP2350320A4 (de) * 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings Verfahren und systeme zur verwendung von exosomen zur bestimmung von phänotypen
CA2753524A1 (en) * 2009-03-06 2010-09-10 Mochida Phamaceutical Co., Ltd. Method for diagnosing endometriosis and diagnostic kit for endometriosis
AU2010321787B2 (en) 2009-11-20 2015-06-11 University Of Louisville Research Foundation, Inc. Biomarkers of cancer
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
WO2011112993A2 (en) * 2010-03-11 2011-09-15 University Of Louisville Research Foundation, Inc. Methods of predicting and decreasing the risk of pregnancy loss
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
WO2013079560A1 (en) 2011-11-29 2013-06-06 Westfälische Wilhelms-Universität Münster Genetic marker for polycystic ovary syndrome (pcos)
US20130183242A1 (en) * 2012-01-18 2013-07-18 University Of Connecticut Methods for identifying tumor-specific polypeptides
US20160003838A1 (en) * 2013-03-14 2016-01-07 Immucor Gti Diagnostics, Inc. Methods and compositions for diagnosing preeclampsia
EP2806274A1 (de) * 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lungenkrebsdiagnoseverfahren und -mittel
US10877033B2 (en) 2013-06-18 2020-12-29 Oxford University Innovation Limited Method of detecting the presence or absence of autoantibodies
CN105658782B (zh) 2013-10-25 2018-08-07 凸版印刷株式会社 膜囊泡回收设备、膜囊泡回收方法及膜囊泡分析方法
EP3517959B1 (de) * 2014-01-21 2021-05-05 Morehouse School of Medicine Exosomen-vermittelter nachweis von hepatitis-c-infektionen
EP3173143A4 (de) 2014-07-24 2018-06-27 Toppan Printing Co., Ltd. Lipidmembranstruktur, immobilisierungsträger für lipidmembranstruktur und verfahren zur zellfusion
EP3281016A1 (de) 2015-04-10 2018-02-14 Applied Proteomics Inc. Proteinbiomarkertafeln zur detektion von kolorektalkrebs und fortgeschrittenem adenom
JP6538887B2 (ja) * 2015-07-03 2019-07-03 カイヴォゲン オサケ ユキチュア 婦人科疾患状態を決定するための方法及びキット
JP7461620B2 (ja) 2015-10-06 2024-04-04 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 治療用化合物及び方法
CN112912400B (zh) 2018-10-19 2025-05-30 明尼苏达大学董事会 Nk接合子分子及其使用方法
CN109633165B (zh) * 2018-12-18 2021-03-09 中国医学科学院基础医学研究所 抗hspa4自身抗体作为乳腺癌诊断或预后评估标志物的应用
CN110687282B (zh) * 2019-08-26 2023-05-23 中国医学科学院肿瘤医院 PD-1和/或p53自身抗体作为肿瘤疗效预测或预后评估的标志物
CN110687281B (zh) * 2019-08-26 2023-05-23 中国医学科学院肿瘤医院 Pd-l1自身抗体在肿瘤预后评估中的应用
CN110632315A (zh) * 2019-10-28 2019-12-31 四川大学华西医院 Msi1自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
WO2024249408A1 (en) * 2023-05-26 2024-12-05 Cz Biohub Sf, Llc Autoantibodies as markers of preterm birth

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
IL51668A (en) 1977-03-16 1981-12-31 Israel State Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4637988A (en) 1981-07-01 1987-01-20 Eastman Kodak Company Fluorescent labels for immunoassay
GB8607101D0 (en) 1986-03-21 1986-04-30 Serono Diagnostics Ltd Immunoassay
US4786594A (en) 1986-05-14 1988-11-22 Syntex (U.S.A.) Inc. Enzyme immunoassay
US5229302A (en) 1988-03-29 1993-07-20 Matsushita Electric Industrial Co., Ltd. Fluorescence immunoassay method utilizing pseudo-antigens combined with fluorescent quenchers
CA2073511A1 (en) 1990-11-14 1992-05-29 Matthew R. Callstrom Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
AU9039691A (en) 1990-11-14 1992-06-11 Southern Research Institute Rapid diagnostic device and kit
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
EP0841945B1 (de) * 1995-08-03 2006-03-08 Rijksuniversiteit te Leiden Antigen presentierende bläschen, die von zellen ableiten
CA2323019C (en) * 1999-10-07 2011-03-08 The United States Of America, As Represented By The Secretary Of Agricul Ture Bacteria and yeasts for reducing fusarium head blight in cereals and selection thereof
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer

Also Published As

Publication number Publication date
IL200026A0 (en) 2010-04-15
EP2111550A4 (de) 2010-06-23
CN101657719A (zh) 2010-02-24
EP2111550B1 (de) 2011-11-30
AU2008207746A1 (en) 2008-07-31
JP5175864B2 (ja) 2013-04-03
IL200026A (en) 2013-12-31
EP2111550A2 (de) 2009-10-28
JP2010517048A (ja) 2010-05-20
WO2008092164A2 (en) 2008-07-31
ZA200905004B (en) 2010-04-28
ES2378490T3 (es) 2012-04-13
AU2008207746B2 (en) 2013-09-05
BRPI0806437A2 (pt) 2011-09-06
US20100055724A1 (en) 2010-03-04
US20120122723A1 (en) 2012-05-17
CA2676148A1 (en) 2008-07-31
WO2008092164A3 (en) 2008-11-06
EP2450702A3 (de) 2012-07-25
EP2450702A2 (de) 2012-05-09

Similar Documents

Publication Publication Date Title
IL200026A0 (en) Methods of detecting autoantibodies for diagnosing and characterizing disorders
DE602007003165D1 (de) Verfahren und Systeme zur Definition, Identifikation und Erfassung geometrischer Eigenschaften
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
WO2007076523A3 (en) Markers and methods for assessing and treating psoriasis and related disorders
DE602008006318D1 (de) Element zur optischen Erfassung, Antriebsverfahren dafür und Sonde zur optischen Erfassung mit dem Element zur optischen Erfassung
CY1115439T1 (el) Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου
ATE410524T1 (de) Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen
MX2020010947A (es) Metodos de tratamiento de enfermedad de alzheimer.
BRPI0912927A2 (pt) "método de detectar um tumor independente de vegf em um indivíduo e método de tratar um tumor independente de vegf em um indivíduo"
HK1214830A1 (zh) 新型ntrk1融合分子及其应用
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE602004005485D1 (de) Verfahren zum beurteilen der nutzungserlaubnis für informationen und inhaltsverbreitungssystem, das dieses verfahren verwendet
DE602008004253D1 (de) Alcotestgerät
MX378733B (es) Métodos in vitro y composiciones para identificar y usarse en el tratamiento de lupus.
WO2008089072A3 (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
EP2569635A4 (de) Verfahren zur diagnose und/oder behandlung von enzephalitis oder epilepsie
ATE513216T1 (de) Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome
BRPI0807690A2 (pt) Tira de teste e medidor de analito de analito e método de produção de tira de teste com lanceta integrada.
GB0524110D0 (en) Biomarkers and methods for identification of agents useful in the treatment of affective disorders
FR2937139B1 (fr) Dispositif de determination de la concentration en monoxyde de carbone et procede.
WO2016112174A3 (en) Biomarkers of Sleep Deprivation and Cognitive Impairment
ATE511636T1 (de) Verfahren zum nachweis biologischer organismen mittels raman-streuung
WO2008104984A3 (en) Diagnosis and prognosis of various types of cancers
ATE551605T1 (de) Verfahren und vorrichtungen zur erkennung von biofilmen
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen